KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crown Castle (CCI) Asset Writedowns and Impairment (2016 - 2025)

Crown Castle's Asset Writedowns and Impairment history spans 17 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 300.0% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $11.0 million, changed 0.0%, while the annual FY2025 figure was $11.0 million, 0.0% changed from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $4.0 million at Crown Castle, up from $3.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $22.0 million in Q2 2023 and bottomed at -$26.0 million in Q4 2022.
  • The 5-year median for Asset Writedowns and Impairment is $3.0 million (2021), against an average of $2.9 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 366.67% in 2022 against a maximum downside of 316.67% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $12.0 million in 2021, then crashed by 316.67% to -$26.0 million in 2022, then rose by 19.23% to -$21.0 million in 2023, then skyrocketed by 104.76% to $1.0 million in 2024, then soared by 300.0% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for CCI's Asset Writedowns and Impairment are $4.0 million (Q4 2025), $3.0 million (Q3 2025), and $2.0 million (Q2 2025).